Search

Search Constraints

You searched for: Author/Creator Avrameas, Alexandre

Search Results

1. Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study. (March 2020)

3. First‐in‐human clinical trial to assess pharmacokinetics, pharmacodynamics, safety, and tolerability of iscalimab, an anti‐CD40 monoclonal antibody. Issue 2 (6th December 2019)

4. O1‐10‐06: Results From a First‐in‐Human Study with the Bace Inhibitor CNP520. (1st July 2016)

5. The BACE‐1 inhibitor CNP520 for prevention trials in Alzheimer's disease. Issue 11 (17th September 2018)